It appears that that the search for a cure for Alzheimer’s has stalled. Each summer the Alzheimer’s Association holds an international summit where researchers report on advances in the understanding of Alzheimer’s disease. This year, the gathering was notable for its lack of new information.
The paper that received the Read More…
At this year’s International Alzheimer’s Conference, the results of the Phase 3 clinical drug trial for LMTM, a drug targeting the build up of Tau protein, were announced. These results have been eagerly awaited, as LMTM is the first drug targeting Tau protein to reach advanced clinical testing. Alzheimer’s is Read More…
In 2014, researchers at the Boston University School of Medicine reported at the Alzheimer’s Association International Conference that the prevalence of dementia among certain populations was decreasing. These findings were not highlighted, in part because the research had not been published in a peer-reviewed journal. And since the specter of Read More…
The Alzheimer’s Association holds an annual international conference that brings together researchers from around the world to discuss developments in Alzheimer’s research. This year’s conference just ended. Here is a brief overview of what Read More…
There was some confusing news announced at the Annual Alzheimer’s International Conference about the number of cases of Alzheimer’s around the world.
First, the good news.
Two separate studies reported a significant drop in the expected number of Read More…
